Canopy Growth (STU:11L) Asset Impairment Charge : €66.8 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Canopy Growth Asset Impairment Charge?

Canopy Growth's Asset Impairment Charge for the three months ended in Sep. 2024 was €12.4 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was €66.8 Mil.

Canopy Growth Asset Impairment Charge Historical Data

The historical data trend for Canopy Growth's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Asset Impairment Charge Chart

Canopy Growth Annual Data

Trend

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Asset Impairment Charge

Get a 7-Day Free Trial

370.63

346.99

238.80

1,481.64

36.56

Canopy Growth Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial															-25.32	17.20	37.12	0.06	12.43

Canopy Growth Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €66.8 Mil.

Canopy Growth Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (STU:11L) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

CGC:USA 11L:Germany WEED:Canada

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Canopy Growth Headlines

No Headlines